OPRK1 and depressive symptom measurement: Indeed, there are a number of studies showing that systemic and central injections of KOR agonists produce dysphoria, anxiety and pro-depressive states in humans and rodents [24]–[28] while KOR antagonists attenuate the anxiety- and depression-like behaviors [29]–[33].